Oncolytic Adenovirus Market

Future Market Insights

Key Insight

The oncolytic adenovirus market is projected to grow from USD 140.2 billion in 2025 to USD 288.9 billion by 2035, at a CAGR of 7.5%. Adenoviruses-based Oncolytic Viruses will dominate with a 47.3% market share, while melanoma will lead the application segment with a 29.8% share.

August 21, 2025

Anurag Sharma

287 Pages

Cite this Report

Oncolytic Adenovirus Market

https://www.futuremarketinsights.com/reports/oncolytic-adenovirus-market

License

Buy Now

Summary ToC Companies

Key Players

CG Oncology Inc
Replimune Group Inc
Thus

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Oncolytic Adenovirus Market

Key Players

Similar Industry Reports